Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer
Clinical trial NCT04192682 · UNKNOWN
Trial details
- NCT number
- NCT04192682
- Sponsor
- Changzhou Cancer Hospital of Soochow University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-08
- Primary completion
- 2021-03-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.